Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study

NCT04332835 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus
Coronavirus Infection

Interventions

DRUG: Plasma
DRUG: Standard Therapy

Sponsor

Universidad del Rosario

Collaborators

[object Object]
[object Object]
[object Object]